Clinical trials
Completed Phase 1/2 Carcinoma, Transitional Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Incyte Biosciences International Sàrl | 2 |
| Aprea Therapeutics | 1 |
| Basilea Pharmaceutica | 1 |
| Cybrexa Therapeutics | 1 |
| Eli Lilly and Company | 1 |
| Genocea Biosciences, Inc. | 1 |
| Gritstone bio, Inc. | 1 |
| Hebrew University of Jerusalem | 1 |
| Inovio Pharmaceuticals | 1 |
| Jason R. Brown | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Transitional Cell | 18 |
| Carcinoma, Non-Small-Cell Lung | 9 |
| Colorectal Neoplasms | 6 |
| Melanoma | 6 |
| Carcinoma, Renal Cell | 5 |
| Squamous Cell Carcinoma of Head and Neck | 5 |
| Stomach Neoplasms | 5 |
| Urinary Bladder Neoplasms | 5 |
| Neoplasm Metastasis | 4 |
| Breast Neoplasms | 3 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.